PHARMA IMPEX
ActiveSummary
The computed 12-month bankruptcy probability of PHARMA IMPEX is 8.7% (elevated). The 2024 annual accounts show negative equity (-€13,123) and a net result of -€3,218. Equity is shrinking by about 82% per year across the filed financial years. Its solvency ranks better than 7% of 25,595 sector peers (NACE 47, financial year 2024). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
2025
25-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 25 days late
28-05
Gazette deed
Registered officeRegistered-office move2 facts ▸
Gazette deed
Registered office
Registered-office move2 facts ▸
- General meeting, 15-04-2025
- Registered-office move, Chaussée de Bruxelles 101 à 6211 Les Bons Villers
2024
28-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 28 days late
2023
15-09
NBB filing
Annual accounts filed
financial year 2022 · micro format · 46 days late
2022
31-12
Financial
Weakest financial yearnet -€7,204
Net result drops to -€7,204, the lowest in the series; recovery starts the following year.
23-08
NBB filing
Annual accounts filed
financial year 2021 · micro format · 23 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 3 deeds read
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.